Juan Carlos Jorge- Rivera
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methyltestosterone | 4 | 2007 | 8 | 1.120 |
Why?
|
| Anabolic Agents | 4 | 2007 | 17 | 0.890 |
Why?
|
| Androstane-3,17-diol | 3 | 2010 | 5 | 0.730 |
Why?
|
| Motor Activity | 5 | 2006 | 393 | 0.590 |
Why?
|
| Conditioning, Operant | 2 | 2006 | 72 | 0.540 |
Why?
|
| Hypospadias | 1 | 2014 | 3 | 0.500 |
Why?
|
| Sex Characteristics | 2 | 2006 | 213 | 0.480 |
Why?
|
| Dihydrotestosterone | 1 | 2010 | 26 | 0.390 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 17 | 0.390 |
Why?
|
| Sexual Behavior, Animal | 1 | 2010 | 51 | 0.380 |
Why?
|
| Nucleus Accumbens | 1 | 2010 | 80 | 0.370 |
Why?
|
| Behavior, Animal | 3 | 2006 | 304 | 0.360 |
Why?
|
| Testosterone | 1 | 2010 | 181 | 0.360 |
Why?
|
| Anxiety | 2 | 2005 | 705 | 0.320 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2007 | 2 | 0.310 |
Why?
|
| Copulation | 1 | 2007 | 3 | 0.310 |
Why?
|
| Mating Preference, Animal | 1 | 2007 | 5 | 0.310 |
Why?
|
| Receptors, GABA-A | 2 | 2010 | 60 | 0.300 |
Why?
|
| Gender Identity | 1 | 2007 | 93 | 0.290 |
Why?
|
| Aggression | 1 | 2007 | 75 | 0.290 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 14 | 0.290 |
Why?
|
| Spatial Behavior | 1 | 2006 | 22 | 0.290 |
Why?
|
| Estrous Cycle | 2 | 2004 | 34 | 0.280 |
Why?
|
| Amygdala | 1 | 2006 | 110 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2010 | 1534 | 0.270 |
Why?
|
| Reward | 1 | 2005 | 73 | 0.260 |
Why?
|
| Pregnenolone | 1 | 2004 | 10 | 0.260 |
Why?
|
| Estradiol | 1 | 2006 | 244 | 0.250 |
Why?
|
| Animals, Newborn | 1 | 2004 | 323 | 0.240 |
Why?
|
| Social Behavior | 1 | 2004 | 124 | 0.230 |
Why?
|
| Rats | 5 | 2010 | 3261 | 0.220 |
Why?
|
| Preoptic Area | 1 | 2002 | 15 | 0.220 |
Why?
|
| Androgens | 1 | 2002 | 87 | 0.200 |
Why?
|
| Animals | 9 | 2010 | 14307 | 0.200 |
Why?
|
| Analysis of Variance | 3 | 2007 | 528 | 0.190 |
Why?
|
| Male | 9 | 2014 | 18870 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2007 | 1530 | 0.190 |
Why?
|
| Female | 9 | 2010 | 19873 | 0.170 |
Why?
|
| Muscimol | 2 | 2006 | 15 | 0.150 |
Why?
|
| Pyridazines | 2 | 2006 | 14 | 0.140 |
Why?
|
| Puerto Rico | 2 | 2014 | 1352 | 0.140 |
Why?
|
| Ovariectomy | 2 | 2006 | 104 | 0.140 |
Why?
|
| Radioimmunoassay | 2 | 2006 | 66 | 0.140 |
Why?
|
| Exploratory Behavior | 2 | 2006 | 72 | 0.140 |
Why?
|
| Mice | 4 | 2007 | 5668 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2014 | 188 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 984 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2014 | 871 | 0.100 |
Why?
|
| Lordosis | 1 | 2010 | 4 | 0.100 |
Why?
|
| Sex Factors | 2 | 2006 | 859 | 0.100 |
Why?
|
| Videotape Recording | 1 | 2010 | 22 | 0.100 |
Why?
|
| Infant | 1 | 2014 | 1014 | 0.100 |
Why?
|
| Prevalence | 1 | 2014 | 1425 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2014 | 1961 | 0.080 |
Why?
|
| 17-Ketosteroids | 1 | 2007 | 1 | 0.080 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 2007 | 2 | 0.080 |
Why?
|
| Adrenal Glands | 1 | 2007 | 17 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2007 | 33 | 0.080 |
Why?
|
| Escape Reaction | 1 | 2007 | 15 | 0.080 |
Why?
|
| Motivation | 1 | 2010 | 415 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 211 | 0.070 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 1 | 2006 | 4 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2006 | 21 | 0.070 |
Why?
|
| GABA Antagonists | 1 | 2006 | 25 | 0.070 |
Why?
|
| Steroids | 1 | 2006 | 43 | 0.070 |
Why?
|
| Maze Learning | 1 | 2006 | 100 | 0.070 |
Why?
|
| Risk Factors | 1 | 2014 | 3414 | 0.070 |
Why?
|
| Adult | 2 | 2014 | 11034 | 0.070 |
Why?
|
| Self Administration | 1 | 2005 | 41 | 0.070 |
Why?
|
| Drug Implants | 1 | 2005 | 19 | 0.070 |
Why?
|
| Central Nervous System Depressants | 1 | 2005 | 37 | 0.070 |
Why?
|
| Estrogens | 1 | 2006 | 190 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 198 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2004 | 50 | 0.060 |
Why?
|
| Organ Size | 1 | 2004 | 148 | 0.060 |
Why?
|
| Vagina | 1 | 2004 | 81 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 468 | 0.060 |
Why?
|
| Young Adult | 1 | 2014 | 4012 | 0.060 |
Why?
|
| Testis | 1 | 2004 | 185 | 0.060 |
Why?
|
| Ethanol | 1 | 2005 | 188 | 0.060 |
Why?
|
| Body Weight | 1 | 2004 | 404 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 78 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2005 | 435 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2002 | 47 | 0.050 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2002 | 75 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2002 | 141 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 490 | 0.050 |
Why?
|
| Gene Expression | 1 | 2002 | 639 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1007 | 0.040 |
Why?
|
| Humans | 2 | 2014 | 34853 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1152 | 0.040 |
Why?
|
| Middle Aged | 1 | 2007 | 9642 | 0.030 |
Why?
|